GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Price-to-Owner-Earnings

Embla Medical hf (OCSE:EMBLA) Price-to-Owner-Earnings : 24.79 (As of May. 12, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Price-to-Owner-Earnings?

As of today (2024-05-12), Embla Medical hf's share price is kr29.00. Embla Medical hf's Owner Earnings per Share (TTM) ended in Mar. 2024 was kr1.17. It's Price-to-Owner-Earnings for today is 24.79.


The historical rank and industry rank for Embla Medical hf's Price-to-Owner-Earnings or its related term are showing as below:

OCSE:EMBLA' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 13.76   Med: 34.18   Max: 63.88
Current: 24.85

During the past 13 years, the highest Price-to-Owner-Earnings of Embla Medical hf was 63.88. The lowest was 13.76. And the median was 34.18.


OCSE:EMBLA's Price-to-Owner-Earnings is ranked better than
60.07% of 278 companies
in the Medical Devices & Instruments industry
Industry Median: 32.685 vs OCSE:EMBLA: 24.85

As of today (2024-05-12), Embla Medical hf's share price is kr29.00. Embla Medical hf's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.93. Therefore, Embla Medical hf's PE Ratio for today is 31.18.

As of today (2024-05-12), Embla Medical hf's share price is kr29.00. Embla Medical hf's EPS without NRI for the trailing twelve months (TTM) ended in was kr0.93. Therefore, Embla Medical hf's PE Ratio without NRI for today is 31.18.

During the past 13 years, Embla Medical hf's highest PE Ratio without NRI was 448.61. The lowest was 16.71. And the median was 33.26.


Embla Medical hf Price-to-Owner-Earnings Historical Data

The historical data trend for Embla Medical hf's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Price-to-Owner-Earnings Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.98 45.07 44.95 39.15 23.79

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.39 31.43 28.56 23.79 28.71

Competitive Comparison of Embla Medical hf's Price-to-Owner-Earnings

For the Medical Devices subindustry, Embla Medical hf's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Price-to-Owner-Earnings falls into.



Embla Medical hf Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Embla Medical hf's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=29.00/1.17
=24.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Embla Medical hf  (OCSE:EMBLA) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Embla Medical hf Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines